Insider · CIK 0001329959

Gallagher Carol Giltner

Reports to the SEC for 13 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001329959

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	TRXBTRex Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2026-06-04	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+42K sh	—	—	42,000
2026-06-04	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−42K sh	—	—	0
2026-06-04	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2025-06-10	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+7,828 sh	—	—	33,012
2025-06-05	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−33.5K sh	—	—	0
2025-06-05	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+33.5K sh	—	—	33,500
2025-06-05	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+33.5K sh	—	—	33,500
2024-06-07	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+67.5K sh	—	—	67,500
2024-06-07	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−67.5K sh	—	—	0
2024-06-06	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+67.5K sh	—	—	67,500
2024-03-31	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+150K sh	—	—	629,608
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,808 sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,555 sh	—	—	6,808
2023-12-29	Mirati Therapeutics, Inc.A Award	Director	AAward	+6,808 sh	$58.75	+$400K	14,363
2023-11-14	ATRAAtara Biotherapeutics, Inc.P Purchase	Director	PPurchase	+91K sh	$0.31	+$28.2K	459,418
2023-11-13	ATRAAtara Biotherapeutics, Inc.P Purchase	Director	PPurchase	+179K sh	$0.22	+$40K	368,438
2023-06-22	Mirati Therapeutics, Inc.A Award	Director	AAward	+7,555 sh	—	—	7,555
2023-06-22	Mirati Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,784
2023-06-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,500
2023-06-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−21.5K sh	—	—	0
2023-06-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+21.5K sh	—	—	21,500
2023-05-31	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+79.5K sh	—	—	79,500
2023-05-31	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+57K sh	—	—	189,418
2022-11-22	Frazier Lifesciences Acquisition CorpClass B Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2022-11-05	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+39K sh	—	—	39,000
2022-11-05	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−39K sh	—	—	39,000
2022-11-04	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39K sh	—	—	39,000
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	—	—	0
2022-06-23	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+31.5K sh	—	—	31,500
2022-06-23	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+20.5K sh	—	—	132,418
2021-06-15	CERTCertara, Inc.A Award	Director	AAward	+7,059 sh	—	—	7,059
2021-06-08	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-08	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+11K sh	—	—	111,818
2021-06-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2020-06-22	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-06-16	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+24.5K sh	—	—	24,500
2020-06-16	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+8,000 sh	—	—	100,818
2020-06-15	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2019-08-27	Turning Point Therapeutics, Inc.Stock Option (right to buy)G Gift	Director	GGift	+30K sh	—	—	30,000
2019-08-27	Turning Point Therapeutics, Inc.Stock Option (right to buy)G Gift	Director	GGift	−30K sh	—	—	0
2019-07-24	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-06-27	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-06-27	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	92,818
2019-06-20	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-01-15	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2018-12-07	TPSTTempest Therapeutics, Inc.A Award	Director	AAward	+23.7K sh	—	—	23,684

Recent filings

Accepted (ET)
Oct 84
Gallagher Carol Giltner0001193125-26-418292
SEC(opens sec.gov)
Jun 54
Gallagher Carol Giltner0001329959-26-000002
SEC(opens sec.gov)
Jun 124
Gallagher Carol Giltner0000905148-25-002142
SEC(opens sec.gov)
Jun 94
Gallagher Carol Giltner0001415889-25-016262
SEC(opens sec.gov)
Jun 104
Gallagher Carol Giltner0001415889-24-016208
SEC(opens sec.gov)
Apr 24
Gallagher Carol Giltner0000905148-24-001057
SEC(opens sec.gov)
Jan 234
Gallagher Carol Giltner0001140361-24-003527
SEC(opens sec.gov)
Jan 34
Gallagher Carol Giltner0001628280-24-000312
SEC(opens sec.gov)
Nov 154
Gallagher Carol Giltner0000905148-23-001457
SEC(opens sec.gov)
Jun 234
Gallagher Carol Giltner0001628280-23-023351
SEC(opens sec.gov)

Companies

Address

C/O TREX BIO, INC. 269 EAST GRAND AVENUE, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080